The Promise and Challenge of Human Microbiota Research
Human-associated microbial communities (microbiota) play an essential role in immunity, health, and disease. Understanding human microbiota and its genomes (microbiome) will increase the possibility of various applications including personalized medicine and cancer immune therapy. Dr. Yu will talk about her research in microbiota, exposures, and lung cancer. She will also discuss the challenges of microbiota research.
Dr. Guoqin Yu got her Ph.D. in Evolution, Ecology and Population Biology at Washington University in St. Louis. She is now a Research Fellow in the Division of Cancer Epidemiology and Genetics, National Cancer Institute. Her research focuses on human microbiota and its relationship to exposures and diseases.
- Cancer Research Data Commons and Other NCI Infrastructures in Support of Data ScienceSeptember 19, 2021AttentiveChrome: Deep Learning for Predicting Gene Expression from Histone ModificationsSeptember 22, 2021“Le Grand et Le Petit”: Splicing Factors SF3B1 and SUGP1 and Their Cancer Mutations Leading to Aberrant Acceptor UsageSeptember 22, 2021The Future of Clinical Trial Data Sharing.... The Art of The PossibleSeptember 23, 2021Genomic Data Commons Single Cell RNA-Seq SupportSeptember 27, 2021Virtual Workshop on Next-Generation Sequencing and Radiomics: Resource Requirements for Acceleration of Clinical Applications Including AISeptember 29, 2021 - September 30, 2021